A substantial advancement in blood sugar management is emerging with the release of tirzepatide at a dosage of 45mg. This innovative version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, https://getidealist.com/story23272765/revolutionary-approach-tirzepatide-dose-for-diabetes-regulation